Is Hoth Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: HOTH) stock is to Strong Buy HOTH stock.
Out of 2 analysts, 1 (50%) are recommending HOTH as a Strong Buy, 1 (50%) are recommending HOTH as a Buy, 0 (0%) are recommending HOTH as a Hold, 0 (0%) are recommending HOTH as a Sell, and 0 (0%) are recommending HOTH as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year HOTH price target, the average HOTH price target is $6.25, with the highest HOTH stock price forecast at $7.50 and the lowest HOTH stock price forecast at $5.00.
On average, Wall Street analysts predict that Hoth Therapeutics's share price could reach $6.25 by Sep 14, 2024. The average Hoth Therapeutics stock price prediction forecasts a potential upside of 448.25% from the current HOTH share price of $1.14.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.